Weighing the Evidence for Prysm iO, Source by Source
Doctors read papers for a living, so this page is set out the way a journal club would want it: each source, who paid for it, what it can bear and what it cannot. The score is a wellness score based on skin carotenoids. Nothing below suggests it says anything about a patient's health, and the awkward details have been left in on purpose.
Four Kinds of Source, Four Different Weights
Not everything cited on this page deserves equal trust, and it helps to see the difference before reading the detail.
- A peer-reviewed review from Yale, covering the measurement method on earlier-generation devices.
- A paper that sets Prysm iO beside a blood test in 97 people, funded by the maker.
- A bulletin from Nu Skin on 589 adults in Shanghai, company-reported and not peer-reviewed.
- A short list of awards, which recognise the product and are not research findings.
The Method's Academic Roots at Yale
Using skin to read carotenoid levels, as a marker of how much fruit and veg someone eats, was shaped by well over ten years of papers. The largest contribution came from a group led by Dr Susan T. Mayne at the Yale School of Public Health and Yale Cancer Center, which collaborated with University of Utah physicists, the people who built the original instruments.
The origin story is a practical one. A study of what inner-city kids' diets looked like would have meant graduate students going out to draw children's blood, and the researchers were reluctant to ask that of them. A scan with no needle got round the problem, and it was a fieldwork problem, not a marketing one.
A 2013 review by the group, in Archives of Biochemistry and Biophysics, gathered up the 1,375-adult survey and the 381-child study they had run themselves, added the published work of others, and contained this sentence:
“Skin carotenoid status as assessed by RRS is an attractive biomarker for use in human studies.”
- Mayne ST, Cartmel B, Scarmo S, Jahns L, Ermakov IV, Gellermann W. “Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies.” Arch Biochem Biophys. 2013;539(2):163-70. PubMed
Read that sentence with care. The devices behind it were earlier-generation resonance Raman spectroscopy (RRS) scanners, not Prysm iO. The review is not about Prysm iO and says nothing on its behalf.
One point the authors raised: when a study relies solely on diet questionnaires, it is hard to tell if anybody has actually altered their eating, and a biological marker helps with that. They treated skin carotenoids as tracking fruit and vegetable intake and as moving with supplements and dietary change. They also said plainly that other influences account for much of the difference from one person to the next, and that bigger studies were still to come. Prysm iO and other later scanners build on this foundation.
Prysm iO Set Against a Blood Draw
There is a way to measure serum carotenoids directly, but it needs a specialist assay that no routine panel includes, and a specialist lab typically takes three weeks over it. With the dermatologist Dr Zoe Draelos, and with Nu Skin's money, a study put 97 volunteers through both a 15-second fingertip scan and that assay so the results could be set side by side.
R² = 0.77
The strength of the link between Prysm iO scores and blood serum carotenoids among 97 people, in research that Nu Skin paid for.
Riggs M, Knaggs H, Lephart ED, Gibb T, Draelos ZD. Food & Nutrition Journal, 2026 (the paper reports R² = 0.7659 for Prysm iO). Read the paper. The study was funded by NSE Products (the maker of Prysm iO) and Brigham Young University.
Every instrument is imperfect. Nu Skin quotes a margin of around ±10% under everyday conditions, so any one result is a snapshot, and the direction of travel over repeated scans tells you more.
The Shanghai Bulletin: Associations, Not Findings From a Trial
A third item comes from Nu Skin itself, describing work at Shanghai Jiao Tong University. There, 589 healthy adults were scanned and their results lined up against what they reported about eating, exercise, sleep and general habits. People scoring higher said they ate more fruit, vegetables, whole grains and freshwater fish, had a balanced BMI, put sleep first, exercised regularly and limited UV exposure. People scoring lower said they ate more fried food, sugary drinks and red meat.
Everything here is correlational, comes from the company and depends on participants describing themselves. No independent peer-reviewed paper has been published on it, so file it as background and let the Yale material count for more.
Source: Nu Skin research bulletin on Prysm iO (NSE Products, 2026), principal investigator Professor Cai of Jiao Tong University. Read the bulletin (PDF). The bulletin also reports a correlation of 0.806 between Prysm iO and BioPhotonic Scanner S3 scores in the same 589 people.
What a GP Can Say When a Patient Asks
Patients who hear about a fingertip scan tend to bring three questions. Is it a blood test? No. The comparison above set a skin reading beside a blood measurement in 97 people, which tells you how two methods relate, and it does not turn the scan into a test your practice would order. Does a higher number mean I am well? The evidence here cannot say so: the Shanghai associations come from self-reports, and the Yale review itself noted that diet explains only part of the variation. Should I change my tablets because of my score? That decision stays with the patient and their prescriber, never with a wellness reading.
A sensible position for a GP is to treat the score as a way into a conversation about food and habits, to say plainly where the evidence stops, and to declare any commercial interest every time. Whether and how you mention Prysm iO to your own patients is for you to settle against GMC guidance, your NHS contract or employment terms, your practice's policy and your indemnifier. Some doctors keep it entirely away from their own patients, and that is a perfectly reasonable choice.
How the Scanner Got Here, Generation by Generation
- 1999: Pharmanex builds its first Biophotonic Scanner. It fills a room and takes roughly an hour to calibrate.
- 2002: a smaller portable unit arrives, based on Raman spectroscopy - a technique roughly a hundred years old, named after the physicist C.V. Raman.
- 2003, 2006, 2013: the S1, S2 and S3 go on sale. The S3 brings Bluetooth and 30-second scans, and ultimately 51 countries and over 25 million scans.
Prysm iO counts as the fourth generation, yet it is a fresh design, not an S3 in a new case. The finger goes on the sensor, not the palm. Its patent-pending “spectral ray” approach studies how skin takes in and reflects light, taking hundreds of thousands of measurements in each scan, on the same basic principle as a pulse oximeter. That differs from Raman spectroscopy, which depends on a signal the sample itself emits.
The AI scoring does still look back to the Raman research. Thirty-second scans and Raman itself are S3 features that Prysm iO does not share. The inheritance is 20-plus years of R&D and the information gathered across more than 25 million scans.
Awards, and a Note on Prysm Certified Products
Outside Nu Skin's own research programme, the product has been given the honours below. They recognise Prysm iO as a product, and none of them is evidence from a study.
- Achievement in Technology Innovation - TITAN Business Awards (winner page)
- Best of Category, Wellness Insight - Globee Business Awards
- Personal category winner - Good Design Awards 2025 (project page)
On the commercial side, some Nu Skin products carry a “Prysm Certified” label, and the company offers a money-back policy for certified, Prysm-eligible products, subject to its Terms and Conditions. This is company policy and has no bearing on anyone's health. Should a patient raise it, direct them to the written terms and keep the subject out of the consultation itself.
Prysm iO is a wellness insight tool and is not a medical device. It is not intended to diagnose, treat, cure or prevent any disease or medical condition, and it is not a substitute for a doctor's own assessment or for medical advice.